- call +1-201-465-4211
- email sales@mrinsights.biz
Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.
Scope of the Report:
This report focuses on the Pandemic Influenza Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Pandemic Influenza Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Influenza A (H1N1) Vaccines
Other
Market Segment by Applications, can be divided into
Adult
Paediatric
There are 15 Chapters to deeply display the global Pandemic Influenza Vaccine market.
Chapter 1, to describe Pandemic Influenza Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pandemic Influenza Vaccine, with sales, revenue, and price of Pandemic Influenza Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pandemic Influenza Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pandemic Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pandemic Influenza Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pandemic Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Influenza A (H1N1) Vaccines
1.2.2 Other
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Paediatric
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Pandemic Influenza Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Pandemic Influenza Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Pandemic Influenza Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Pandemic Influenza Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valneva
2.5.1 Business Overview
2.5.2 Pandemic Influenza Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valneva Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin
2.6.1 Business Overview
2.6.2 Pandemic Influenza Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Chiron Panacea
2.7.1 Business Overview
2.7.2 Pandemic Influenza Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Solvay and Serum Institute of India Pvt. Ltd.
2.8.1 Business Overview
2.8.2 Pandemic Influenza Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sementis
2.9.1 Business Overview
2.9.2 Pandemic Influenza Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sementis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pandemic Influenza Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pandemic Influenza Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pandemic Influenza Vaccine Market Analysis by Regions
4.1 Global Pandemic Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5 North America Pandemic Influenza Vaccine by Countries
5.1 North America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6 Europe Pandemic Influenza Vaccine by Countries
6.1 Europe Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.4 France Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pandemic Influenza Vaccine by Countries
7.1 Asia-Pacific Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.5 India Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8 South America Pandemic Influenza Vaccine by Countries
8.1 South America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pandemic Influenza Vaccine by Countries
9.1 Middle East and Africa Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
10 Global Pandemic Influenza Vaccine Market Segment by Type
10.1 Global Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Influenza A (H1N1) Vaccines Sales Growth and Price
10.2.1 Global Influenza A (H1N1) Vaccines Sales Growth (2013-2018)
10.2.2 Global Influenza A (H1N1) Vaccines Price (2013-2018)
10.3 Other Sales Growth and Price
10.3.1 Global Other Sales Growth (2013-2018)
10.3.2 Global Other Price (2013-2018)
11 Global Pandemic Influenza Vaccine Market Segment by Application
11.1 Global Pandemic Influenza Vaccine Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Paediatric Sales Growth (2013-2018)
12 Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.1 Global Pandemic Influenza Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Pandemic Influenza Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.2 Europe Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.4 South America Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.3 Pandemic Influenza Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Pandemic Influenza Vaccine Market Share Forecast by Type (2018-2023)
12.4 Pandemic Influenza Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Pandemic Influenza Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pandemic Influenza Vaccine Picture
Table Product Specifications of Pandemic Influenza Vaccine
Figure Global Sales Market Share of Pandemic Influenza Vaccine by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
